Top

Familial Cancer

Published in:

01-11-2005

Patient Satisfaction of BRCA1/2 Genetic Testing by Women at High Risk for Breast Cancer Participating in a Prevention Trial

Authors: Jennifer R. Klemp, Anne O’Dea, Carolyn Chamberlain, Carol J. Fabian

Published in: Familial Cancer | Issue 4/2005

Title: Patient Satisfaction of BRCA1/2 Genetic Testing by Women at High Risk for Breast Cancer Participating in a Prevention Trial
Authors: Jennifer R. Klemp
Anne O’Dea
Carolyn Chamberlain
Carol J. Fabian
Publication date: 01-11-2005
Publisher: Kluwer Academic Publishers
Published in: Familial Cancer / Issue 4/2005
Print ISSN: 1389-9600
Electronic ISSN: 1573-7292
DOI: https://doi.org/10.1007/s10689-005-1474-y

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras

Prof. Fabrice Barlesi

Developed by: Springer Medicine

At a glance: The STEP trials

Springer Medicine

Please log in to get access to this content

Other articles of this Issue 4/2005

Key word Index Volume 4

Neurofibromatosis 2 (NF2) and Malignant Mesothelioma in a Man with a Constitutional NF2 Missense Mutation

Contents Volume 4

Behavioral and Economic Impact of a Familial History of Cancers

Linkage of a Pedigree Drawing Program and Database to a Program for Determining BRCA Mutation Carrier Probability

MLH1 and MSH2 Mutations in Colombian Families with Hereditary Nonpolyposis Colorectal Cancer (Lynch syndrome) – Description of Four Novel Mutations

Keynote webinar | Spotlight on antibody–drug conjugates in cancer